Acute effects of feeding fructose, glucose and sucrose on blood lipid levels and systemic inflammation by Faizan Jameel et al.
Jameel et al. Lipids in Health and Disease 2014, 13:195
http://www.lipidworld.com/content/13/1/195RESEARCH Open AccessAcute effects of feeding fructose, glucose and
sucrose on blood lipid levels and systemic
inflammation
Faizan Jameel1, Melinda Phang1,3, Lisa G Wood1,2 and Manohar L Garg1*Abstract
Background: Recent studies have demonstrated a relationship between fructose consumption and risk of
developing metabolic syndrome. Mechanisms by which dietary fructose mediates metabolic changes are poorly
understood. This study compared the effects of fructose, glucose and sucrose consumption on post-postprandial
lipemia and low grade inflammation measured as hs-CRP.
Methods: This was a randomized, single blinded, cross-over trial involving healthy subjects (n = 14). After an
overnight fast, participants were given one of 3 different isocaloric drinks, containing 50 g of either fructose or
glucose or sucrose dissolved in water. Blood samples were collected at baseline, 30, 60 and 120 minutes post
intervention for the analysis of blood lipids, glucose, insulin and high sensitivity C-reactive protein (hs-CRP).
Results: Glucose and sucrose supplementation initially resulted in a significant increase in glucose and insulin levels
compared to fructose supplementation and returned to near baseline values within 2 hours. Change in plasma
cholesterol, LDL and HDL-cholesterol (measured as area under curve, AUC) was significantly higher when participants
consumed fructose compared with glucose or sucrose (P < 0.05). AUC for plasma triglyceride levels however remained
unchanged regardless of the dietary intervention. Change in AUC for hs-CRP was also significantly higher in subjects
consuming fructose compared with those consuming glucose (P < 0.05), but not sucrose (P = 0.07).
Conclusion: This study demonstrates that fructose as a sole source of energy modulates plasma lipids and
hsCRP levels in healthy individuals. The significance of increase in HDL-cholesterol with a concurrent increase in
LDL-cholesterol and elevated hs-CRP levels remains to be delineated when considering health effects of feeding
fructose-rich diets.
Registration number for clinical trials: ACTRN12614000431628Introduction
Fructose, commonly known as fruit sugar, is also a major
component of sweeteners such as table sugar, honey and
high fructose corn syrup (HFCS). Fructose intake has
quadrupled since the beginning of 20th century, partly
because of the introduction of HFCS [1]. Increased fruc-
tose consumption can lead to a parallel rise in cardiovas-
cular disease risk factors, i.e. increase in blood lipids
[2,3], development of insulin resistance [4,5], alteration
in the production of satiety hormones (insulin, leptin* Correspondence: manohar.garg@newcastle.edu.au
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unless otherwise stated.and ghrelin) [3], increase in inflammatory biomarkers
[6,7] and increase in obesity [5,8]. Since similar effects
do not occur following the intake of starch or glucose, it
has been proposed that fructose-induced metabolic
changes are not mediated by excessive sugar intake in
general, but are specific to fructose. Precise underlying
mechanisms by which fructose consumption may induce
negative metabolic effects are not clear. One recent
study demonstrated that in young healthy individuals,
consumption of glucose and fructose drinks resulted in
markedly different hemodynamic responses, with fruc-
tose stimulating a sustained increase in blood pressure
[9]. These observations support the concept that dietsThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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to increased cardiovascular disease risk.
The aim of this study was to investigate the effects of
fructose compared to glucose and sucrose consumption,
on postprandial lipemia and low grade inflammation in
healthy subjects. Previous studies have examined the ef-
fects of feeding sugars as part of a meal on cardiovascu-
lar disease indices. In the current study, we looked at
postprandial lipid and low grade inflammation following
a single dose of sugary drink given as a sole source of
energy after an overnight fast.
Methods
Study population
Healthy male and female adults (n = 14) between the ages
of 18-60 years were recruited by advertisement and under-
went study procedures at the Nutraceuticals Research
Group Clinic rooms, University of Newcastle, NSW,
Australia. Exclusion criteria were: diagnosed hyperlipid-
aemia, diabetes, gastrointestinal disorders, currently on
fructose/sugar restricted diet, vegan diet or weight loss
program, undergone any surgical procedure for obesity,
pregnant or lactating mother, taking lipid-lowering or
anti-inflammatory drugs and BMI >30 kg/m2. Participants
were asked to complete a medical questionnaire, Inter-
national Physical Activity Questionnaire (IPAQ) [10] and a
24 hr food record. Approval for the study was granted by
the Human Research Ethics Committee of the University
of Newcastle, Australia. All participants provided written
informed consent and the study was conducted in accord-
ance with The Declaration of Helsinki. The trial was regis-
tered with the Australian & New Zealand Clinical Trials
Registry (ACTRN12614000431628). Body composition
was assessed by bioimpedance analysis (BIA) using single
frequency bioelectrical impedance apparatus (Maltron
International, Essex, UK). Measurements were conducted
in the supine position, with participants wearing light
clothing and without shoes, in the morning after a mini-
mum 10 hour fast. Participants were asked to refrain from
physical exertion and alcohol consumption for 24 hours
prior to testing.
Study design
The trial was a randomised, single blinded, controlled
cross-over intervention trial. Participants visited the re-
search facility on three separate occasions, where they
consumed one of 3 different isocaloric sugary drinks on
each occasion, with a minimum of one week wash out
period in between. The participants were randomised to
consume: 1) 50 g fructose dissolved in 300 ml of water
2) 50 g glucose dissolved in 300 ml of water and 3) 50 g
sucrose dissolved in 300 ml of water. Each sugar drink
contained 10 ml of lemon juice to provide a more
uniform and palatable taste. Participants were asked toconsume the sweetened drinks within 2-3 minutes and
compliance was observed. Block randomization tech-
nique was used for allocation of participants to treat-
ment arms. During each visit, a fasting blood sample
was collected prior to supplementation, then 30, 60 and
120 minutes following intake of the sugary drink. The
participants remained in the research facility until the
final sample was collected and were asked to limit phys-
ical activity during their time in the research facility.
Laboratory methods
Blood samples at base line, 30, 60 and 120 minutes were
collected into tubes pre-coated with EDTA, lithium hep-
arin and sodium fluoride by venepuncture. EDTA blood
tubes were centrifuged for 10 minutes at 3000 g at 4°C
for separation of plasma and stored at -80°C for further
use. The lithium heparin tubes for blood lipids and so-
dium fluoride tubes for blood glucose and insulin meas-
urement were analysed by Hunter New England Area
Pathology Services (Newcastle). Twenty four hour food
recalls were collected by face to face interview by an in-
house dietician. Food records collected from participants
were entered into FoodWorks Version 7.0.291 database
(Xyris Software Pty Ltd, Queensland, Australia) to ana-
lyse daily energy and nutrient intake of participants.
Statistical analysis
All data are presented as mean ± SEM. Area under the
curve (AUC) was calculated by the trapezoid method. Pre-
liminary assumption testing was done to check for nor-
mality, linearity, outliers and homogeneity of variance
with no serious violations noted for all test variables
within the three different groups of fructose, glucose and
sucrose. Comparisons between different groups were
made with one-way repeated measures ANOVA and post
hoc Tukey testing. A probability level of p < 0.05 was
adopted throughout to determine statistical significance
unless otherwise mentioned. All statistical analyses were
carried out with SPSS software (version 21.0; SPSS Inc.,
Chicago, IL, USA).
Results
All participants were healthy and their baseline values of
anthropometric measurements and blood biomarkers
were within normal range (Table 1).
As shown in Figure 1A, at 30 minutes, fructose con-
sumption was followed by an increase in blood glucose
levels that was significantly lower than following glucose
and sucrose consumption. At 60 and 120 minutes there
were no differences between the 3 groups. The overall
change in blood glucose levels followed by fructose con-
sumption measured as area under the curve (AUC), was
significantly lower than following glucose supplementation
(Figure 1B).
Table 1 Baseline values of anthropometric measurements,




n 14 07 07
Age (Yrs) 28.0 ± 0.79 28.7 ± 0.64 27.3 ± 1.45
Weight (kg) 69.6 ± 3.48 78.8 ± 4.26 60.4 ± 2.50
BMI (kg/m2) 24.2 ± 0.72 25.6 ± 0.82 22.8 ± 0.98
SMM (kg) 30.8 ± 2.44 34.1 ± 2.72 27.4 ± 3.83
FFM (kg) 51.1 ± 3.48 60.0 ± 4.44 42.1 ± 2.49
PBF (%) 27.1 ± 1.88 24.0 ± 1.86 30.1 ± 2.96
Waist: hip 0.8 ± 0.00 0.9 ± 0.00 0.8 ± 0.12
Glucose (mmol/L) 4.7 ± 0.12 4.7 ± 0.19 4.6 ± 0.16
Cholesterol (mmol/L) 4.2 ± 0.22 4.3 ± 0.37 4.1 ± 0.25
Triglyceride (mmol/L) 1.01 ± 0.20 1.35 ± 0.35 0.67 ± 0.11
LDL-C (mmol/L) 2.43 ± 0.22 2.72 ± 0.39 2.14 ± 0.19
HDL-C (mmol/L) 1.32 ± 0.13 1.00 ± 0.09 1.65 ± 0.19
Total/HDL ratio 3.6 ± 0.38 4.5 ± 0.52 2.6 ± 0.25
Insulin (mIU/L) 9.2 ± 1.09 9.5 ± 1.56 8.8 ± 1.65
CRP (mg/L) 1.5 ± 0.31 1.7 ± 0.47 1.5 ± 0.45
B: Daily energy and nutrient intake
Daily intake Total Males Females
Energy No DF (kj) 8619 ± 1001 10077 ± 1797 7161 ± 641
Energy DF (kj) 8820 ± 1016 10292 ± 1828 7348 ± 645
Protein (g) 89.37 ± 11.78 107.82 ± 21.00 70.92 ± 6.86
Fat (g) 73.29 ± 10.20 90.56 ± 16.78 56.03 ± 8.99
Cholesterol (mg) 204.46 ± 43.01 227.38 ± 81.43 181.53 ± 34.81
Carbohydrate (g) 481.54 ± 224.56 293.89 ± 58.01 669.18 ± 451.01
Sugar (g) 88.21 ± 12.24 110.05 ± 21.72 76.20 ± 11.41
Glucose (g) 10.40 ± 2.32 9.54 ± 4.27 11.27 ± 2.19
Sucrose (g) 32.70 ± 9.06 35.50 ± 17.15 29.90 ± 7.67
Bound fructose (g) 16.35 ± 4.53 17.75 ± 8.57 14.95 ± 3.83
Free fructose (g) 12.56 ± 2.27 11.60 ± 3.93 13.51 ± 2.57
Total fructose (g) 28.91 ± 6.51 29.55 ± 12.36 28.46 ± 5.56
Lactose (g) 12.36 ± 2.09 16.13 ± 2.92 8.60 ± 2.40
Maltose (g) 18.01 ± 5.84 25.74 ± 10.06 10.29 ± 5.15
Mean values ± standard error of mean.
BMI, Body mass index; SMM, Skeletal muscle mass, FM, Fat Free Mass; PBF,
Percentage Body Fat; LDL-C, Low Density Lipoprotein cholesterol; HDL-C, High
Density Lipoprotein cholesterol; CRP, c-Reactive Protein, DF: dietary fibre.
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consumption led to a smaller increase in insulin levels
than glucose or sucrose. At 60 minutes, insulin levels in
the fructose fed group remained lower than the glucose
fed group. However, at 120 minutes, there were no dif-
ferences in insulin levels across intervention groups. The
overall increase in the insulin levels, measured as AUC,was significantly lower when participants consumed
fructose compared to glucose or sucrose (Figure 1D).
Fructose consumption led to an increase in total chol-
esterol compared to glucose and sucrose consumption
(Figure 2A). The effects were still apparent at 60 minutes,
however at 120 minutes there were no differences be-
tween groups. The overall increase in plasma total chol-
esterol measured as AUC was significantly higher when
participants consumed fructose compared to glucose or
sucrose (Table 2). At 30 minutes after fructose con-
sumption we observed an increase in LDL-cholesterol
compared to glucose and sucrose (Figure 2B). The ef-
fects were still apparent at 60 minutes. However, at
120 minutes there were no differences between groups.
Overall, the increase in LDL cholesterol measured as
AUC was significantly higher when participants con-
sumed fructose compared to glucose or sucrose (Table 2).
Similarly, fructose consumption was followed by an in-
crease in HDL-cholesterol at 30 minutes in comparison
to glucose and sucrose (Figure 2C). The effects were still
apparent at 60 minutes; however, at 120 minutes there
were no differences between groups. The overall in-
crease in HDL cholesterol measured as AUC was signifi-
cantly higher when participants consumed fructose
compared to glucose or sucrose (Table 2).
Comparison of all treatment groups revealed no sig-
nificant difference in TG levels at 30 minutes. At 60 mi-
nutes, subjects fed fructose had lower TG levels
compared to glucose. At 120 minutes there were no
differences between groups (Figure 2D). There were
overall no significant differences in plasma triglyceride
levels (measured as AUC) regardless of the dietary inter-
vention (Table 2). Comparison between all treatment
groups revealed no significant change in the ratio of
total/HDL-cholesterol at all the time points (p > 0.005).
Furthermore, the overall change in the ratio of total/
HDL-cholesterol measured as AUC was not different
between groups (Table 2).
Figure 3A demonstrates that fructose consumption
was followed by an increase in hs-CRP level at 30 mi-
nutes when compared to glucose and sucrose. At 60 mi-
nutes, hs-CRP was not different compared to glucose or
sucrose and at 120 minutes there were no differences
between groups. There was, however, an overall increase
in hs-CRP levels measured as AUC in subjects who con-
sumed fructose compared with those who consumed
glucose (p < 0.05), but not sucrose (Figure 3B).
Discussion
This study was designed to examine the metabolic con-
sequences of sugar consumption when it is used as a
sole source of energy. Participants consumed fructose in
the fasting state in the morning; therefore, majority of
the sugar consumed would be used to produce energy
BC D
A
Figure 1 Kinetics of change and area under the curve (AUC) for blood glucose (mmol/L) (A and B respectively) and insulin (mIU/L)
(C and D respectively) after the fructose, glucose or sucrose supplementations. Values without a common superscript are significantly





Figure 2 Kinetics of change for (A) total cholesterol (mmol/L); (B) LDL-C (mmol/L); (C)HDL-C (mmol/L) and (D) triglyceride (mmol/L) after
the fructose, glucose or sucrose supplementations. Values without a common superscript are significantly different; P < 0.05.
Jameel et al. Lipids in Health and Disease 2014, 13:195 Page 4 of 7
http://www.lipidworld.com/content/13/1/195
Table 2 Area under curve (AUC) for blood lipids derived
from kinetics of change
Area under curve (AUC)
Fructose (F) Glucose (G) Sucrose (S)
Cholesterol (mmol/L) 4.09 ± 1.67a -0.90 ± 1.25b -2.41 ± 0.85b
LDL-C (mmol/L) 4.50 ± 2.03a -3.22 ± 1.69b -3.87 ± 1.25b
HDL-C (mmol/L) 6.69 ± 1.56a 0.63 ± 1.70b -0.84 ± 0.60b
Triglyceride (mmol/L) -2.45 ± 2.37 5.65 ± 3.52 1.79 ± 2.68
Total/HDL ratio -1.97 ± 0.92 -0.62 ± 0.73 -1.57 ± 0.95
Mean values± standard error of mean; LDL-C, Low Density Lipoprotein cholesterol;
HDL-C, High Density Lipoprotein cholesterol; Values without a common superscript
are significantly different, P<0.05.
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time of day [11]. Fructose was a sole source of energy
without accompanying meal and there was no other nu-
trient to augment postprandial lipemia. Consumption of
sugar sweetened beverages in the morning in the fasting
state separated the effect of fructose from excess energy
intake which may be a confounder in the overfeeding
studies [11]. This is the first study to report the conse-
quences of consuming a beverage containing fructose,
glucose or sucrose as a sole source of energy, on post-
prandial lipid levels and inflammation markers. Acute
fructose consumption in a single dose of 50 g/day which
provided approximately 8% of daily energy in the form
of a beverage, resulted in a significant increase in the
plasma levels of total, LDL and HDL cholesterol and the
acute phase pro-inflammatory marker hs-CRP, compared
to the same dose of glucose or sucrose. Interestingly, no
significant change in TG levels was observed.
The change in fasting glucose and insulin responses
was modest in fructose compared with glucose and su-
crose groups. This modest increase in the glucose and
insulin levels after fructose consumption is consistent
with previous studies [12-14]. The blunted rise in insulin
in response to fructose consumption is consistent with
the blunted rise in blood glucose level, but may also
be partly attributed to less release of intestinal incretinA
Figure 3 Kinetics of change (A) and area under the curve (AUC) (B) for C
Values without a common superscript are significantly different; P < 0.05.hormone that binds to β-cells of the pancreas leading to
reduce secretion of insulin [15].
Changes in total, LDL and HDL-cholesterol levels were
significantly higher when participants consumed fructose
compared with glucose or sucrose sweetened beverage.
Previous studies examining postprandial lipemia following
fructose consumption were either focused on triglyceride
levels only [11,14,16-19] or demonstrate heterogeneous
results. Two studies showed no effects of fructose on
plasma total, LDL or HDL-cholesterol levels [20,21], while
another 2 studies [2,22] showed a significant increase in
fasting serum total and LDL cholesterol following 4-5
weeks of consuming fructose-rich diets compared to the
starch diet. The reason for the increase in postprandial
levels of total, LDL and HDL cholesterol in subjects who
consumed fructose in our study is not known. Since no nu-
trients, other than sugars, were included in the test bever-
ages, the lipoproteins measured were almost exclusively of
hepatic origin. Whether fructose can influence total and
LDL-cholesterol levels by blocking LDL-receptors or affect
HDL cholesterol via CETP or reverse cholesterol transport
is not known, therefore, merits further investigation.
Dietary fructose has been previously shown to cause
either no change [2,21,23,24] or an increase in fasting
plasma triglycerides in healthy subjects [20,25]. Our re-
sults showed no significant change in postprandial trigly-
ceride levels irrespective of the type of sugar. These
findings are in agreement with a meta-analysis reporting
no significant change in post-prandial TG level unless
the amount of fructose exceeds 50 g/day [26]. On the
other hand, the present results are in contrast with lit-
erature reporting an increase in TG after acute fructose
consumption [3,11,14,16-18,25,27]. This disagreement
may be due to the accompanying meal with consump-
tion of the fructose beverage in previously published
studies. In our study, due to the absence of other energy
yielding nutrients, the clearance rate of triglycerides can
be expected to be higher, resulting in overall no change.
Moreover the shorter duration (2 hours) of our study
compared to the study by Bohannan et al. [19] (5 hours)B
RP (mg/L) after the fructose, glucose or sucrose supplementations.
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Therefore, the lipemic effects of fructose may depend on
the dose and duration of fructose feeding and whether
fructose is consumed in the presence or absence of other
energy nutrients.
The pro-inflammatory biomarker that we examined in
this study was hs-CRP. The area under the curve for hs-
CRP level was significantly increased in the fructose group
compared with glucose, but not with sucrose. This is the
first time, to our knowledge, in healthy and normal weight
adult subjects, that acute fructose consumption has been
shown to increase hs-CRP levels. Previous studies report-
ing an increase in hs-CRP level were either conducted in a
mixed population of lean and overweight individuals [12]
or a long term intervention study [6]. The proposed mech-
anism of fructose-induced oxidative stress and inflamma-
tion markers (TNFα, IL-6, IL-1β) [28] potentially resulting
in an increase synthesis of hs-CRP merits further investi-
gation. Fructose has been shown to induce oxidative stress
in cellular [29] and animal models [30], thereby, may re-
sult in elevated levels of pro-inflammatory mediators.
Whether fructose can directly (without conversion to fat)
influence inflammation pathways (leukotriene synthesis,
expression of adhesion molecules etc) remains to be delin-
eated. In conclusion, this study demonstrates that fructose
as a sole source of energy modulates plasma lipids and
hsCRP levels in healthy individuals. However, the signifi-
cance of increase in HDL-cholesterol with a concurrent
increase in LDL-cholesterol and elevated hsCRP levels re-
mains to be delineated when considering health effects of
feeding fructose-rich diets.
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